Compare Charles River Laboratories Intl. Inc (CRL) vs HP Inc (HPQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs HP Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $232.3 (market cap $11.14B), while HP Inc trades at $24.44 (market cap $22.52B). The key difference: HP Inc is far larger — about 2× Charles River Laboratories Intl. Inc's market cap, and HP Inc pays a 4.87% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | HPQ | |
|---|---|---|
Market Cap | $11.14B | $22.52B |
Sector | Health | Technology |
52-Week High | $233.60 | $29.35 |
52-Week Low | $145.57 | $18.20 |
Enterprise Value | $14.00B | $29.69B |
Dividend Yield | — | 4.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.
Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.
HPQ trades at $24.77, up 2.27% today, with a bullish technical outlook and strong earnings momentum, beating estimates for three consecutive quarters. The stock offers a 4.8% dividend yield and trades at attractive valuation multiples, including a P/E of 9.17 and P/S of 0.41. Recent partnerships with OpenAI and Ferrari highlight strategic moves to enhance AI capabilities and innovation in the PC market.
The outlook is positive due to undervaluation, dividend income, and AI-driven growth potential, but risks include PC market volatility, competitive pressures, and reliance on hardware sales. Analyst consensus is mixed with a hold rating, but technical indicators suggest near-term strength with support at $24 and resistance at $25-26.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About HP Inc
HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →
